Chan, Andrew (2017). Clinical commentary on 'Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis', by Foley et al. Multiple sclerosis journal, 23(10), pp. 1427-1429. Sage 10.1177/1352458517712868
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
1352458517712868.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (412kB) |
This clinical commentary discusses the occurrence of drug-induced aseptic meningitis in patients undergoing natalizumab treatment and other immunotherapies.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DCR Unit Sahli Building > Forschungsgruppe Neurologie 04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology |
UniBE Contributor: |
Chan, Andrew Hao-Kuang |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1352-4585 |
Publisher: |
Sage |
Language: |
English |
Submitter: |
Stefanie Hetzenecker |
Date Deposited: |
13 Oct 2017 11:23 |
Last Modified: |
02 Mar 2023 23:29 |
Publisher DOI: |
10.1177/1352458517712868 |
PubMed ID: |
28639492 |
Uncontrolled Keywords: |
Natalizumab adverse drug reaction disease-modifying therapies drug-induced aseptic meningitis |
BORIS DOI: |
10.7892/boris.102105 |
URI: |
https://boris.unibe.ch/id/eprint/102105 |
Actions (login required)
 |
Edit item |